Literature DB >> 21691119

Shear stress induces the release of an endothelial elastase: role in integrin α(v)β(3)-mediated FGF-2 release.

Theres Hennig1, Christina Mogensen, Julian Kirsch, Ulrich Pohl, Torsten Gloe.   

Abstract

BACKGROUND/AIMS: Laminar shear stress is an important stimulus in the endothelium-dependent control of vascular tone and of vascular remodeling processes. Based on previous studies demonstrating integrin-mediated release of fibroblast growth factor 2 (FGF-2), we investigated whether shear stress-induced integrin activation requires the involvement of an extracellular protease.
METHODS: Cultured porcine aortic endothelial cells (PAEC) were exposed to laminar shear stress (16 dyn/cm(2)), whereas static cells served as controls.
RESULTS: Exposure of PAEC to shear stress led to an increased activity of a protease in supernatants. This protease could be characterized as elastase but was different from neutrophil and pancreatic elastases. The enhanced activity was accompanied by the activation of integrin α(v)β(3) and p38 MAPK, and followed by an increased FGF-2 concentration in the supernatant. Pretreatment with inhibitors of either elastase or integrin α(v)β(3) resulted in a reduction of FGF-2 release. The observed effects of shear stress on integrin α(v)β(3) and p38 MAPK activation, as well as on FGF-2 release could be mimicked by application of pancreatic elastase to static endothelial cells.
CONCLUSION: By inducing the release of an endothelial elastase, shear stress induces an integrin-dependent release of FGF-2 from endothelial cells.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691119     DOI: 10.1159/000327009

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  8 in total

Review 1.  Fluid resuscitation in sepsis: the great 30 mL per kg hoax.

Authors:  Paul E Marik; Liam Byrne; Frank van Haren
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

2.  Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow.

Authors:  Peter L Voyvodic; Daniel Min; Robert Liu; Evan Williams; Vipul Chitalia; Andrew K Dunn; Aaron B Baker
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

Review 3.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

4.  Vascular endothelial cells mediate mechanical stimulation-induced enhancement of endothelin hyperalgesia via activation of P2X2/3 receptors on nociceptors.

Authors:  Elizabeth K Joseph; Paul G Green; Oliver Bogen; Pedro Alvarez; Jon D Levine
Journal:  J Neurosci       Date:  2013-02-13       Impact factor: 6.167

5.  Inhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo.

Authors:  Liangru W Contois; Abebe Akalu; Jennifer M Caron; Eric Tweedie; Alexandra Cretu; Terry Henderson; Lucy Liaw; Robert Friesel; Calvin Vary; Peter C Brooks
Journal:  Angiogenesis       Date:  2014-09-24       Impact factor: 9.596

6.  Simultaneous Upregulation of Elastolytic and Elastogenic Factors Are Necessary for Regulated Collateral Diameter Expansion.

Authors:  Elizabeth Andraska; Nolan Skirtich; Dylan McCreary; Rohan Kulkarni; Edith Tzeng; Ryan McEnaney
Journal:  Front Cardiovasc Med       Date:  2022-01-12

Review 7.  Structural Remodeling of the Extracellular Matrix in Arteriogenesis: A Review.

Authors:  Rohan Kulkarni; Elizabeth Andraska; Ryan McEnaney
Journal:  Front Cardiovasc Med       Date:  2021-11-05

8.  Involvement of plasmalogens in post-natal retinal vascular development.

Authors:  Sarah Saab; Bénédicte Buteau; Laurent Leclère; Alain M Bron; Catherine P Creuzot-Garcher; Lionel Bretillon; Niyazi Acar
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.